JMP Securities Upgrades BioCryst Pharma (BCRX) to Market Outperform
Tweet
Share
E-mailGet Alerts BCRX Hot Sheet
Price: $9.65 --0%
Rating Summary:
18 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 5 | New: 16
Rating Summary:
18 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 5 | New: 16
Join SI Premium – FREE
JMP Securities upgraded BioCryst Pharma (NASDAQ: BCRX) from Market Perform to Market Outperform with a price target of $3.00.
For an analyst ratings summary and ratings history on BioCryst Pharma click here. For more ratings news on BioCryst Pharma click here.
Shares of BioCryst Pharma closed at $2.04 yesterday.
For an analyst ratings summary and ratings history on BioCryst Pharma click here. For more ratings news on BioCryst Pharma click here.
Shares of BioCryst Pharma closed at $2.04 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DA Davidson Upgrades Palantir (PLTR) to Buy, 'A Gift for Our Nation's 250th Birthday'
- BioCryst Pharma (BCRX) PT Raised to $17 at Jefferies
- UBS Upgrades Watches of Switzerland (WOSG:LN) to Buy
Create E-mail Alert Related Categories
Hot Upgrades, UpgradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
